According to the NCI website, Triptorelin is a synthetic decapeptide agonist analog of luteinizing hormone releasing hormone (LHRH).

Indikationen/Anwendungsmöglichkeiten gemäss Arzneimittel-Kompendium der Schweiz®:

Symptomatische Therapie des fortgeschrittenen hormonabhängigen Prostatakarzinoms.

Link to Drug Information Portal
Link to MedlinePlus, a service of the U.S. National Library of Medicine, National Institutes of Health
Link to National Cancer Institute
Link zu Wiki
Link zu PharmaWiki
Link to Physicians Desk Reference (PDR)
Link zur Fachinformation des Arzneimittel-Kompendium der Schweiz
Info for Patients presented by Scott Hamilton from Chemocare.com